A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis. - Wikidata - wikimedia - TriplyDB

A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis.

A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis.

http://www.wikidata.org/entity/Q34733739

about

CCR5 monoclonal antibodies for HIV-1 therapy Tick-borne encephalitis: A review of epidemiology, clinical characteristics, and management Dengue virus requires the CC-chemokine receptor CCR5 for replication and infection development Tick-borne encephalitis virus induces chemokine RANTES expression via activation of IRF-3 pathway Could FIV zoonosis responsible of the breakdown of the pathocenosis which has reduced the European CCR5-Delta32 allele frequencies Tick-borne flaviviruses: dissecting host immune responses and virus countermeasures The African diaspora: history, adaptation and health The CCR5Δ32 (rs333) polymorphism is not a predisposing factor for severe pandemic influenza in the Brazilian admixed population.Chemokine receptor 5 △32 allele in patients with severe pandemic (H1N1) 2009 Immunogenetic factors associated with severe respiratory illness caused by zoonotic H1N1 and H5N1 influenza viruses.Controlling the HIV/AIDS epidemic: current status and global challenges Genetic Modulation Therapy Through Stem Cell Transplantation for Human Immunodeficiency Virus 1 Infection.Impact of smoking on dendritic cell phenotypes in the airway lumen of patients with COPD.A role for the chemokine RANTES in regulating CD8 T cell responses during chronic viral infection CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission Polymorphisms in chemokine receptor 5 and Toll-like receptor 3 genes are risk factors for clinical tick-borne encephalitis in the Lithuanian population The chemokine receptor CCR5, a therapeutic target for HIV/AIDS antagonists, is critical for recovery in a mouse model of Japanese encephalitis A functional Toll-like receptor 3 gene (TLR3) may be a risk factor for tick-borne encephalitis virus (TBEV) infection Clinical use of CCR5 inhibitors in HIV and beyond Elevation of matrix metalloproteinase-9 level in cerebrospinal fluid of tick-borne encephalitis patients is associated with IgG extravassation and disease severity.The contribution of rodent models to the pathological assessment of flaviviral infections of the central nervous system The expression of the chemokine receptor CCR5 in tick-borne encephalitis.Mice with different susceptibility to tick-borne encephalitis virus infection show selective neutralizing antibody response and inflammatory reaction in the central nervous system.Encephalitic Arboviruses: Emergence, Clinical Presentation, and Neuropathogenesis.CXCR3-deficiency protects influenza-infected CCR5-deficient mice from mortality.Maraviroc concentrates in the cervicovaginal fluid and vaginal tissue of HIV-negative women.Lymphoma diagnosis and plasma Epstein-Barr virus load during vicriviroc therapy: results of the AIDS Clinical Trials Group A5211.C-C chemokine receptor type five (CCR5): An emerging target for the control of HIV infection.Staphylococcus aureus Leukocidin LukED and HIV-1 gp120 Target Different Sequence Determinants on CCR5.Expert opinion on vaccination of travelers against Japanese encephalitis.A vaccine against CCR5 protects a subset of macaques upon intravaginal challenge with simian immunodeficiency virus SIVmac251.Maraviroc: a new CCR5 antagonist.Dual targeting of CCR2 and CCR5: therapeutic potential for immunologic and cardiovascular diseases.Pharmacogenomic implications of the evolutionary history of infectious diseases in Africa Clinical implications of new findings in HIV basic research.Neuroinvasive flavivirus infections.The role of chemokines in the pathogenesis of neurotropic flaviviruses.Targeting CCL5 in inflammation.The potential to target CCL5/CCR5 in breast cancer.Chemokine receptors as important regulators of pathogenesis during arboviral encephalitis

P2860

Q22242739-B214524F-D1B6-4A74-A09E-BEC9017C9E0F Q24457191-490DA4B6-2C15-452C-851C-392FC07FF17A Q26700116-7DA20165-7561-4B61-93AD-52F65D6C3280 Q27468806-664219B2-248C-4A76-AEE0-14ACFF2878AF Q27487233-38A78585-2476-4ED9-813F-158C30BCF285 Q27490363-DC4060A4-E705-44CD-9619-47800C6883EF Q28075805-18FFFAC0-91D2-454D-876C-68D6B192962E Q30377320-9A247DC4-EE52-4E8D-B272-8CFD66C44A51 Q30394185-973B771C-2FFF-421E-9A7C-A37A78C0F76F Q30409873-6DA12A0C-9E2E-47F5-A194-ED98B81CC2C1 Q30420558-43EBBC31-DE32-463B-9916-AD98016470C0 Q33563686-40110DC3-98C4-4F7A-BDD2-57751708CC9E Q33613164-67C5A31F-A440-4833-B261-8213483337B9 Q33981265-E8914421-C7DB-4FBC-B5F9-8AD9939DA141 Q34108023-669C2A49-1CC8-4B63-B5D4-9178EC94F148 Q34196240-0C102885-9333-45F2-8D3C-FF2B4CBC5D15 Q34427503-E526331D-857D-4C24-9E35-B6CEFC467C17 Q34764439-AD179DD9-1E24-4D79-9291-92554A083F58 Q35018145-D5D3BB9F-A877-461E-B3A7-1D983CCF5A92 Q35040641-2DE68D6A-18A7-436F-93D9-9ECEAA140211 Q36089982-8E41DF3C-BE08-47C3-A71A-6AFB5BC23DF1 Q36606525-D6C52E7A-0D36-4A11-AABE-A1D2284166D5 Q36980550-57B402FF-938C-4454-83ED-036DC5B44B6F Q37136479-F608BB54-FC5B-4308-B522-B4AF37BA66DD Q37358025-2EABDBA0-2903-4631-B83B-5462FD533DB1 Q37362444-CAED69EF-46C6-4803-AAF8-F6BEA6ABFADD Q37373656-9E0668F3-41D1-4BE2-9536-B997DAFD6502 Q37463869-E5A68680-CE60-4B30-932D-007C78603ABE Q37502946-09621ED1-18B6-491F-AFC6-FC7FE9628EE5 Q37524448-0EB4DAEA-1506-4485-A7F2-0796CCD7BB59 Q37547093-78519F76-515D-44DB-A3E2-56513F631DBD Q37557671-A1BF3516-489A-4972-AB74-8FE952877A49 Q37723178-0BF83E31-7C4C-4BC6-B595-D7AE7DE8DD5B Q37737731-F207B3FE-69F7-40C3-AD78-23265EDB635D Q37775523-139358DE-DD1D-410D-9486-800F0E96EBFF Q37956596-225B6406-A5B1-417E-8A35-A6B7BD5FF248 Q38006657-29C41B70-44E0-4FA5-AE21-D05F24729934 Q38148785-0BC3485B-3FBB-4E97-966F-7B7360B212CA Q38254356-4CA080DE-3FBE-4048-B584-5B73DE05C759 Q38261006-2A259448-3A08-47D5-BE0B-DE56246F907C

P2860

A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis.

http://www.wikidata.org/entity/Q34733739

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

A deletion in the chemokine re ...... d with tickborne encephalitis.

@ast

A deletion in the chemokine re ...... d with tickborne encephalitis.

@en

A deletion in the chemokine receptor 5

@nl

type

label

A deletion in the chemokine re ...... d with tickborne encephalitis.

@ast

A deletion in the chemokine re ...... d with tickborne encephalitis.

@en

A deletion in the chemokine receptor 5

@nl

prefLabel

A deletion in the chemokine re ...... d with tickborne encephalitis.

@ast

A deletion in the chemokine re ...... d with tickborne encephalitis.

@en

A deletion in the chemokine receptor 5

@nl

P1433

Q34733739-6D9525F9-E505-4AFA-AF3E-2B0DB94BE3BA

P1476

Q34733739-77205D72-8A7B-4D9C-96E8-6B1B8D9CF6DA

P2093

Q34733739-279FDCD8-768C-4BDB-BAA4-4796B820A67F

Q34733739-3B5E3E02-D18A-4082-BEC0-EAE8F806DF5E

Q34733739-7CD30516-B820-46D9-A0A8-2E395370F893

Q34733739-8462E1E2-9693-4303-A514-8EBBD1FC166A

Q34733739-BFF1C8B5-BD31-48E0-9479-E81CF59EE658

Q34733739-C37F8DA1-C55E-48D8-82AE-27226BF51244

Q34733739-DD2F260E-A182-4E13-8808-E920BAC3E836

Q34733739-FDA2E8D4-4D07-4B93-90E6-275C7C6763FD

P2860

Q34733739-0041427C-172C-4A6A-8410-4CF47AC9CEF7

Q34733739-21324E95-DC1F-4706-B080-8218624B7494

Q34733739-251D6F5B-DF9C-4414-9BD2-C8609DBBAA9B

Q34733739-29B566DA-29A0-47DE-BCA7-10E7572D9667

Q34733739-34EA5A1D-9E54-4F3B-BDC5-C372BC658F55

Q34733739-51192467-3EEC-47D4-9079-7BAC91E1D074

Q34733739-624F1D62-D51A-4D19-B38B-A8C61B31FCBB

Q34733739-68EF5FB5-DDF0-41A4-8F33-2400AD94AE52

Q34733739-85194151-4D55-42A4-AAA5-93694BD42C15

Q34733739-DF2D6DC8-5276-446D-BDA7-B097C3650F5F

P304

Q34733739-75483EB8-88E2-41E8-BDF1-C383D2094AD6

P31

Q34733739-532DF9DE-918C-4EF4-8BFC-A04359863D37

P356

Q34733739-550A49C0-C059-4695-B60C-4C892F3B1B20

P407

Q34733739-9847980F-E9FE-49B6-A275-9C43F276A816

P433

Q34733739-4C4CEC60-4C0C-4B4C-A1E5-3B149E17C02E

P478

Q34733739-8707FDF2-B66C-4173-8478-1DF4DF56B196

P577

Q34733739-276B9E7D-4D09-4FDB-ACE4-17EDFE5C25BC

P5875

Q34733739-31680EDC-0700-446D-8583-2ACB67517393

P698

Q34733739-7648ABF6-65BB-48D3-8E7A-71112C490FD3

P356

P1433

The Journal of Infectious Diseases

P1476

A deletion in the chemokine re ...... d with tickborne encephalitis.

@en

P2093

Ake Lundkvist

http://www.w3.org/2001/XMLSchema#string

Aukse Mickiene

http://www.w3.org/2001/XMLSchema#string

Britt Akerlind

http://www.w3.org/2001/XMLSchema#string

Cecilia Ax

http://www.w3.org/2001/XMLSchema#string

Elin Kindberg

http://www.w3.org/2001/XMLSchema#string

Lars Lindquist

http://www.w3.org/2001/XMLSchema#string

Lennart Svensson

http://www.w3.org/2001/XMLSchema#string

Sirkka Vene

http://www.w3.org/2001/XMLSchema#string

P2860

Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes.

Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection

CCR5 deficiency increases risk of symptomatic West Nile virus infection

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

The deltaccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe.

A nonsense mutation (428G-->A) in the fucosyltransferase FUT2 gene affects the progression of HIV-1 infection.

Chemokines: attractive mediators of the immune response.

Tick-borne encephalitis--pathogenesis, clinical course and long-term follow-up.

Diagnosis of tick-borne encephalitis.

Frequencies of 32 base pair deletion of the (Delta 32) allele of the CCR5 HIV-1 co-receptor gene in Caucasians: a comparative analysis.

P304

266-269

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/524709

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

197

http://www.w3.org/2001/XMLSchema#string

P577

2008-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5671715

http://www.w3.org/2001/XMLSchema#string

P698

18179389

http://www.w3.org/2001/XMLSchema#string